A Study to Learn About How a New Pneumococcal Vaccine Works in Adults

Running, not enrolling · Phase 1 · Has a placebo group

Conditions studied: Streptococcus Pneumoniae

In brief

The purpose of this study is to learn about the safety and tolerability of a pneumococcal vaccine in adults. Participants will receive either: * an experimental PG4 vaccine * a PG4 vaccine comparator * a standard 20vPnC vaccine comparator * placebo. A placebo does not have any medicine in it but looks just like the study medicine. Participants will take part in this study for up to 18 months depending on which group they are assigned to. During this time, the participants will receive up to two doses of study vaccine or comparator and take part in follow-up visits. At these clinic visits, participants will be asked if any side effects were experienced. The participants will also have to give blood samples during clinic visits.

Key facts

Study ID
NCT07086677
Run by
Pfizer
People needed
380
Starts
2025-07-22
Expected to finish
2027-10-21
Last updated by the study team
2026-06-22

Who can join

Age: 65 and older, up to 84. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.